• IRIDEX received a Nasdaq notice on Aug. 27, 2026 for failing the $1 minimum bid price rule for 30 straight business days.
• The stock remains listed during a 180-day cure period running through Feb. 23, 2027.
• Compliance requires a closing bid of at least $1 for 10 consecutive business days within the cure period.
• Missing the deadline could trigger a second 180-day window if listing standards are met, or lead to delisting risk.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRIDEX Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-380229), on September 02, 2026, and is solely responsible for the information contained therein.